When these hit hard, your prescriber might recommend reducing your dose temporarily
Semaglutide is a GLP-1 receptor agonist, while tirzepatide combines GIP and GLP-1 receptor agonism, producing stronger effects on satiety and weight loss
With supply issues and drug shortages, that might not always be possible
The disease can range from simple steatosis, where fat accumulates in liver cells without causing inflammation, to non-alcoholic steatohepatitis (NASH), which involves inflammation and liver cell damage that can eventually lead to fibrosis and cirrhosis
The injections are easy-to-use, with complete instructions included
The supplement strategies for tirzepatide users often include electrolyte support that serves double duty for hydration and UTI prevention